Agilent Technologies [A] vs Idexx Laboratories [IDXX] Detailed Stock Comparison

Agilent Technologies Inc.

NYSE
Loading...

Idexx Laboratories, Inc.

NASDAQ
Loading...

TLDR: Quick Comparison Summary

Based on 21 vital metrics comparison: Agilent Technologies Inc. wins in 10 metrics, Idexx Laboratories, Inc. wins in 10 metrics, with 0 ties. Both stocks appear equally matched on key metrics.

View Metrics Details

Vital Metrics Comparison

Metric Agilent Technologies Inc. Idexx Laboratories, Inc. Better
P/E Ratio (TTM) 25.67 42.92 Agilent Technologies Inc.
Price-to-Book Ratio 4.76 27.85 Agilent Technologies Inc.
Debt-to-Equity Ratio 51.39 60.83 Agilent Technologies Inc.
PEG Ratio -7.19 2.41 Idexx Laboratories, Inc.
EV/EBITDA 17.32 31.12 Agilent Technologies Inc.
Profit Margin (TTM) 18.26% 24.62% Idexx Laboratories, Inc.
Operating Margin (TTM) 22.86% 29.76% Idexx Laboratories, Inc.
EBITDA Margin (TTM) 22.86% 29.76% Idexx Laboratories, Inc.
Return on Equity 19.95% 66.20% Idexx Laboratories, Inc.
Return on Assets (TTM) 8.53% 25.59% Idexx Laboratories, Inc.
Free Cash Flow (TTM) $1.15B $1.04B Agilent Technologies Inc.
Dividend Yield 0.68% N/A N/A
1-Year Return 10.90% 7.30% Agilent Technologies Inc.
Price-to-Sales Ratio (TTM) 4.65 10.38 Agilent Technologies Inc.
Enterprise Value $34.13B $46.85B Idexx Laboratories, Inc.
EV/Revenue Ratio 4.83 10.89 Agilent Technologies Inc.
Gross Profit Margin (TTM) 52.61% 60.35% Idexx Laboratories, Inc.
Revenue per Share (TTM) $25 $54 Idexx Laboratories, Inc.
Earnings per Share (Diluted) $4.53 $13.07 Idexx Laboratories, Inc.
Beta (Stock Volatility) 1.30 1.72 Agilent Technologies Inc.
Short % of Float 1.83% 2.74% Agilent Technologies Inc.

Agilent Technologies Inc. vs Idexx Laboratories, Inc. Stock Performance Analysis

Loading Price Chart...

A
IDXX

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Agilent Technologies Inc.-3.41%-2.11%3.78%7.87%-3.22%-4.70%
Idexx Laboratories, Inc.1.63%1.57%7.79%-2.79%-18.64%-14.92%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Agilent Technologies Inc.10.90%7.19%-10.46%186.24%282.67%444.17%
Idexx Laboratories, Inc.7.30%16.12%-6.68%539.84%1,431.62%2,795.61%

Performance & Financial Health Analysis: Agilent Technologies Inc. vs Idexx Laboratories, Inc.

MetricAIDXX
Market Information
Market Cap i$32.65B$44.66B
Market Cap CategoryLarge capLarge cap
10 Day Avg. Volume i1,922,585480,502
90 Day Avg. Volume i1,892,452516,114
Last Close$131.46$570.00
52 Week Range$108.35 - $160.27$506.91 - $769.98
% from 52W High-17.98%-25.97%
All-Time High$179.57 (Aug 30, 2021)$769.98 (Nov 26, 2025)
% from All-Time High-26.79%-25.97%
Growth Metrics
Quarterly Revenue Growth0.07%0.14%
Quarterly Earnings Growth-0.04%0.15%
Financial Health
Profit Margin (TTM) i0.18%0.25%
Operating Margin (TTM) i0.23%0.30%
Return on Equity (TTM) i0.20%0.66%
Debt to Equity (MRQ) i51.3960.83
Cash & Liquidity
Book Value per Share (MRQ)$24.44$20.14
Cash per Share (MRQ)$6.22$2.26
Operating Cash Flow (TTM) i$1.40B$1.18B
Levered Free Cash Flow (TTM) i$855.88M$790.74M
Dividends
Last 12-Month Dividend Yield i0.68%N/A
Last 12-Month Dividend i$1.01N/A

Valuation & Enterprise Metrics Analysis: Agilent Technologies Inc. vs Idexx Laboratories, Inc.

MetricA (Apr 26, 2026)IDXX (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i25.6742.92
Forward P/E i17.6734.19
PEG Ratio i-7.192.41
Price to Sales (TTM) i4.6510.38
Price to Book (MRQ) i4.7627.85
Market Capitalization
Market Capitalization i$32.65B$44.66B
Enterprise Value i$34.13B$46.85B
Enterprise Value Metrics
Enterprise to Revenue i4.8310.89
Enterprise to EBITDA i17.3231.12
Risk & Other Metrics
Beta i1.301.72
Book Value per Share (MRQ) i$24.44$20.14

Financial Statements Comparison: Agilent Technologies Inc. vs Idexx Laboratories, Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricA (2025)IDXX (2025)
Revenue/Sales i6.95B4.30B
Cost of Goods Sold i3.31B1.64B
COGS % of Revenue i47.6%38.2%
Gross Profit i3.64B2.66B
Gross Margin i52.4%61.8%
Research & Development i455.00M251.21M
Operating Income (EBIT) i1.48B1.36B
Operating Margin i21.3%31.6%
EBITDA i1.84B1.51B
EBITDA Margin i26.4%35.0%
Pre-Tax Income i1.44B1.32B
Pre-Tax Income % of Revenue i20.7%30.8%
Income Tax i132.00M264.73M
Income Tax % of Revenue i1.9%6.2%
Net Income (Profit) i1.30B1.06B
Profit Margin i18.8%24.6%

Balance Sheet & Liquidity Metrics

MetricA (2025)IDXX (2025)
Cash & Equivalents i1.79B180.07M
Total Current Assets i4.59B1.41B
Total Current Assets % of Revenue i66.1%32.9%
Total Current Liabilities i2.35B1.15B
Total Current Liabilities % of Revenue i33.8%26.7%
Long-Term Debt i3.05B475.99M
Long-Term Debt % of Revenue i43.9%11.1%
Total Shareholders Equity i6.74B1.61B
Retained Earnings i1.39B6.39B
Retained Earnings % of Revenue i20.0%148.5%
Property, Plant & Equipment i0123.23M

Cash Flow Statement Comparison

MetricA (2025)IDXX (2025)
Operating Cash Flow i1.51B1.17B
Operating Cash Flow % of Revenue i21.7%27.3%
Capital Expenditures i-407.00M-124.68M
Free Cash Flow i1.15B1.04B
FCF Margin i16.6%24.2%
Debt Repayment i-3.00M-428.39M
Common Stock Repurchase i-425.00M-1.22B

Short Interest & Institutional Ownership Analysis

MetricAIDXX
Shares Short i4.55M1.91M
Short Ratio i1.933.85
Short % of Float i1.83%2.74%
Shares Outstanding i282.70M79.71M
Float Shares i281.64M78.75M
% Held by Insiders i0.19%0.71%
% Held by Institutions i93.87%96.04%
% Held by Public i5.94%3.25%

Dividend Analysis & Yield Comparison: Agilent Technologies Inc. vs Idexx Laboratories, Inc.

MetricAIDXX
Last 12-Month Dividend i$1.01N/A
Last 12-Month Dividend Yield i0.68%N/A
3-Year Avg Annual Dividend i$0.97N/A
3-Year Avg Dividend Yield i0.18%N/A
3-Year Total Dividends i$2.91N/A
Ex-Dividend DateJan 06, 2026N/A